Clinical Trial Update: Safety and Immune Response to an Investigational Dengue Type 2 Vaccine [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and immune response of an investigational Dengue Type 2 vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Dengue Type 2 vaccine (investigational) (DENV-2 vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Dengue Virus | Phase 1 | Status: COMPLETED